World of DTC Marketing

AUGUST 12, 2022

He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData. In my opinion, PhRMA has zero credibility.

Pharma 255

Pharma Retail Pharmaceutical Pharmaceutical manufacturing 255

World of DTC Marketing

DECEMBER 10, 2020

SUMMARY: (JAMA) The median drug wholesale list price (as defined by Average Wholesale Price) increased by 129% from 2010-2016, while median patient out-of-pocket costs increased by 53% and median insurance payments after rebates and discounts increased by 64%. Say goodbye to all the supposed goodwill.

Insurance 181

Insurance Pharma Manufacturing Retail 181

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Marketing 69

Marketing Pharmaceutical Leads Manufacturing 69

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

Impetus Digital

AUGUST 2, 2024

Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology.

Pharma 92

Pharma Manufacturing Medicine Marketing 92

PM360

AUGUST 26, 2024

Cancer detection involves measurement of biomarkers, which leads to the application of targeted therapy (which targets specific cancer cells). In Germany, medicine approval by the European Medicines Agency (EMA) leads to reimbursement of the medicine by statutory health insurance, with free pricing in the first year.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. This complements other savings programs already offered by Sanofi, including offering Lantus for $35 per month to people without insurance.

Retail 52

Retail Sales Pharmaceutical manufacturing Insurance 52